Ci Investments Inc. Biogen Inc. Transaction History

Ci Investments Inc.

$26.3 Billion
Q3 2024

A detailed history of Ci Investments Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Ci Investments Inc. holds 5,854 shares of BIIB stock, worth $879,212. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,854

Previous 6,243 6.23%

Holding current value

$879,212

Previous $1.45 Million 21.56%

% of portfolio

0.0%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$189.07 - $236.8 $73,548 - $92,115	-389 Reduced 6.23%	5,854 $1.14 Million
Q2 2024 Aug 12, 2024	SELL	$190.52 - $236.72 $238,340 - $296,136	-1,251 Reduced 16.69%	6,243 $1.45 Million
Q1 2024 May 13, 2024	BUY	$212.02 - $267.71 $456,267 - $576,111	2,152 Added 40.28%	7,494 $1.62 Million
Q4 2023 Feb 12, 2024	SELL	$222.59 - $267.94 $64,551 - $77,702	-290 Reduced 5.15%	5,342 $1.38 Million
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $105,626 - $119,216	417 Added 8.0%	5,632 $1.45 Million
Q2 2023 Aug 11, 2023	BUY	$275.25 - $318.06 $381,221 - $440,513	1,385 Added 36.16%	5,215 $1.49 Million
Q1 2023 May 12, 2023	BUY	$256.56 - $292.34 $258,355 - $294,386	1,007 Added 35.67%	3,830 $1.07 Million
Q4 2022 Feb 10, 2023	BUY	$252.44 - $306.72 $47,963 - $58,276	190 Added 7.22%	2,823 $782,000
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $28,424 - $39,195	146 Added 5.87%	2,633 $703,000
Q2 2022 Aug 12, 2022	SELL	$187.54 - $223.02 $289,936 - $344,788	-1,546 Reduced 38.33%	2,487 $507,000
Q1 2022 May 12, 2022	BUY	$193.77 - $244.14 $126,531 - $159,423	653 Added 19.32%	4,033 $849,000
Q4 2021 Feb 11, 2022	BUY	$223.92 - $287.77 $21,272 - $27,338	95 Added 2.89%	3,380 $811,000
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $238,560 - $311,109	843 Added 34.52%	3,285 $930,000
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $550,893 - $882,088	-2,127 Reduced 46.55%	2,442 $846,000
Q1 2021 May 13, 2021	BUY	$242.95 - $284.63 $490,030 - $574,098	2,017 Added 79.04%	4,569 $1.28 Million
Q4 2020 Feb 09, 2021	BUY	$236.26 - $355.63 $206,727 - $311,176	875 Added 52.18%	2,552 $625,000
Q3 2020 Nov 09, 2020	BUY	$264.77 - $305.71 $87,638 - $101,190	331 Added 24.59%	1,677 $476,000
Q2 2020 Aug 07, 2020	BUY	$258.66 - $342.55 $46,300 - $61,316	179 Added 15.34%	1,346 $360,000
Q1 2020 Aug 07, 2020	BUY	$268.85 - $341.04 $98,399 - $124,820	366 Added 45.69%	1,167 $369,000
Q4 2019 Feb 11, 2020	BUY	$220.06 - $304.07 $156,682 - $216,497	712 Added 800.0%	801 $238,000
Q3 2019 Nov 08, 2019	SELL	$217.44 - $243.88 $1.84 Million - $2.06 Million	-8,452 Reduced 98.96%	89 $21,000
Q3 2018 Nov 09, 2018	BUY	$293.51 - $383.83 $2.51 Million - $3.28 Million	8,541 New	8,541 $3.02 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ci Investments Inc. with notifications on news.

Account

Ci Investments Inc. Biogen Inc. Transaction History